Mayne Pharma has been awarded $13.2 in legal costs plus interest after the Supreme Court of New South Wales upheld the company in proceedings against Cosette Pharmaceuticals over the US company's attempted termination of the Scheme Implementation Deed signed in early 2025.
Mayne Pharma awarded legal costs as business expansion gains momentum
May 25, 2026 Latest NewsBioPharma
Latest Video
New Stories
-
The 'Dispatched' Podcast - Season 5, Episode 22
July 3, 2026 - - Podcast -
Is that a subtle but meaningful shift conceding the potential need for a response to global realities?
July 3, 2026 - -
New once weekly therapy offers extended protection for people with haemophilia A
July 3, 2026 - - Latest News -
Nothing else grows below this self-serving and broken institutional framework
July 3, 2026 - - Latest News -
Nurse prescribing reform set to expand access to PBS subsidised medicines
July 3, 2026 - - Latest News -
Medicines Australia chief says next negotiation is about getting comfortable with being uncomfortable
July 3, 2026 - - Latest News -
Minister looks to be sending a very clear message about these therapies and the PBS
July 2, 2026 - - Latest News

